Back to Search

Circulating Tumor Cells, from Biotech Innovation to Clinical Utility Part B: Volume 392

AUTHOR Gerratana, Lorenzo; Reduzzi, Carolina; Reduzzi, Carolin et al.
PUBLISHER Academic Press (06/05/2025)
PRODUCT TYPE Hardcover (Hardcover)

Description
Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology.
Show More
Product Format
Product Details
ISBN-13: 9780443136559
ISBN-10: 0443136556
Binding: Hardback or Cased Book (Sewn)
Content Language: English
More Product Details
Page Count: 208
Carton Quantity: 34
Product Dimensions: 6.37 x 0.64 x 9.17 inches
Weight: 1.03 pound(s)
Country of Origin: US
Subject Information
BISAC Categories
Science | Life Sciences - Developmental Biology
Science | Life Sciences - Molecular Biology
Science | Statistics
Descriptions, Reviews, Etc.
publisher marketing
Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology.
Show More
Your Price  $236.61
Hardcover